161 related articles for article (PubMed ID: 17449553)
1. Interstitial norepinephrine concentrations in skeletal muscle of ischemic heart failure.
Xing J; Koba S; Kehoe V; Gao Z; Rice K; King N; Sinoway L; Li J
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1190-5. PubMed ID: 17449553
[TBL] [Abstract][Full Text] [Related]
2. Effects of locally administered desipramine on myocardial interstitial norepinephrine levels.
Yamazaki T; Akiyama T
J Auton Nerv Syst; 1996 Dec; 61(3):264-8. PubMed ID: 8988484
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nonexocytotic norepinephrine release by desipramine reduces myocardial infarction size.
Richardt D; Dendorfer A; Tölg R; Dominiak P; Richardt G
Can J Physiol Pharmacol; 2006 Nov; 84(11):1185-9. PubMed ID: 17218983
[TBL] [Abstract][Full Text] [Related]
4. Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter.
Parrish DC; Gritman K; Van Winkle DM; Woodward WR; Bader M; Habecker BA
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H99-H106. PubMed ID: 17951370
[TBL] [Abstract][Full Text] [Related]
5. P2X receptor-mediated muscle pressor reflex in myocardial infarction.
Gao Z; Xing J; Sinoway L; Li J
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H939-45. PubMed ID: 17012345
[TBL] [Abstract][Full Text] [Related]
6. Epinephrine in the heart: uptake and release, but no facilitation of norepinephrine release.
Lameris TW; de Zeeuw S; Duncker DJ; Tietge W; Alberts G; Boomsma F; Verdouw PD; van den Meiracker AH
Circulation; 2002 Aug; 106(7):860-5. PubMed ID: 12176961
[TBL] [Abstract][Full Text] [Related]
7. Interstitial ATP and norepinephrine concentrations in active muscle.
Li J; King NC; Sinoway LI
Circulation; 2005 May; 111(21):2748-51. PubMed ID: 15911708
[TBL] [Abstract][Full Text] [Related]
8. Interstitial K+ concentration in active muscle after myocardial infarction.
Li J; Gao Z; Kehoe V; Sinoway LI
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H808-13. PubMed ID: 17012361
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine reuptake is impaired in skeletal muscle of hypertensive rats in vivo.
Cabassi A; Vinci S; Quartieri F; Moschini L; Borghetti A
Hypertension; 2001 Feb; 37(2 Pt 2):698-702. PubMed ID: 11230359
[TBL] [Abstract][Full Text] [Related]
10. [Effect of local and systemic desipramine administration on extracellular noradrenaline in the myocardium of rats].
Gilinskiĭ MA; Lante KE
Ross Fiziol Zh Im I M Sechenova; 2002 Dec; 88(12):1550-8. PubMed ID: 12852214
[TBL] [Abstract][Full Text] [Related]
11. Dialysate dihydroxyphenylglycol as a window for in situ axoplasmic norepinephrine disposition.
Yamazaki T; Akiyama T; Kitagwa H; Kawada T; Sunagawa K
Neurochem Int; 2001 Mar; 38(3):287-92. PubMed ID: 11099788
[TBL] [Abstract][Full Text] [Related]
12. Sympathetic nerve responses to muscle contraction and stretch in ischemic heart failure.
Koba S; Xing J; Sinoway LI; Li J
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H311-21. PubMed ID: 17965282
[TBL] [Abstract][Full Text] [Related]
13. Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure.
Du XJ; Cox HS; Dart AM; Esler MD
Cardiovasc Res; 1999 Sep; 43(4):919-29. PubMed ID: 10615419
[TBL] [Abstract][Full Text] [Related]
14. Effects of omega-conotoxin GVIA on cardiac sympathetic nerve function.
Yahagi N; Akiyama T; Yamazaki T
J Auton Nerv Syst; 1998 Jan; 68(1-2):43-8. PubMed ID: 9531444
[TBL] [Abstract][Full Text] [Related]
15. Impaired modulation of sympathetic vasoconstriction in contracting skeletal muscle of rats with chronic myocardial infarctions: role of oxidative stress.
Thomas GD; Zhang W; Victor RG
Circ Res; 2001 Apr; 88(8):816-23. PubMed ID: 11325874
[TBL] [Abstract][Full Text] [Related]
16. Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF.
Liang CS; Himura Y; Kashiki M; Stevens SY
Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1863-72. PubMed ID: 12384464
[TBL] [Abstract][Full Text] [Related]
17. Effect of sustained limb ischemia on norepinephrine release from skeletal muscle sympathetic nerve endings.
Kuroko Y; Tokunaga N; Yamazaki T; Akiyama T; Ishino K; Sano S; Mori H
Neurochem Int; 2006 Oct; 49(5):448-53. PubMed ID: 16632086
[TBL] [Abstract][Full Text] [Related]
18. Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo.
Lameris TW; de Zeeuw S; Alberts G; Boomsma F; Duncker DJ; Verdouw PD; Veld AJ; van Den Meiracker AH
Circulation; 2000 Jun; 101(22):2645-50. PubMed ID: 10840018
[TBL] [Abstract][Full Text] [Related]
19. Exogenous angiotensin II does not facilitate norepinephrine release in the heart.
Lameris TW; de Zeeuw S; Duncker DJ; Alberts G; Boomsma F; Verdouw PD; van den Meiracker AH
Hypertension; 2002 Oct; 40(4):491-7. PubMed ID: 12364352
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction.
Soeki T; Kishimoto I; Schwenke DO; Tokudome T; Horio T; Yoshida M; Hosoda H; Kangawa K
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H426-32. PubMed ID: 18024547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]